MEDWIN FRANCE

Medwin France specializes in two primary device categories: a central venous catheter navigation system control unit, which aids in precise, imaging-guided placement of catheters, and an enteral feeding pump, which delivers controlled nutrient administration. These devices address critical needs in vascular access and patient nutrition support.

Medwin France is based in the United States. Since the company operates within the U.S., its devices are subject to FDA regulations, including classification under the FDA’s device hierarchy. The U.S. regulatory framework ensures that devices like the central venous catheter navigation system and enteral feeding pump meet safety and performance standards before listing in the FDA’s Unique Device Identifier (UDI) database.

Medwin France’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical because it provides transparent, standardized identification of medical devices, enabling healthcare providers, regulators, and manufacturers to track product details, compliance status, and recall information. Listing in the UDI database ensures traceability and supports post-market surveillance.

Medwin France’s devices are classified as Class II under regulatory standards. This classification indicates that they pose moderate risk and require special controls beyond general controls to ensure their safety and effectiveness. Class II devices undergo rigorous evaluation to mitigate risks, such as infection risks for central venous catheters or dosing errors for enteral feeding pumps, ensuring they meet performance requirements before authorization.